This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignee: Neos Therapeutics, LP. Active years: 2012-2016.
Company Filing History:
Years Active: 2012-2016
Title: The Innovative Contributions of Daniel Lockhart
Introduction
Daniel Lockhart is a notable inventor based in Euless, TX (US). He has made significant contributions to the field of pharmaceutical formulations, holding a total of 5 patents. His work focuses on developing advanced methods for drug delivery systems, which are crucial for improving patient outcomes.
Latest Patents
Lockhart's latest patents include innovative compositions and methods for making sustained release liquid formulations. This invention involves creating shelf-stable liquid formulations that allow for the controlled release of active agents. The process includes blending controlled release microbeads with a thixotropic solution, ensuring minimal bubble formation during mixing. Another significant patent relates to formulating and designing liquid drug suspensions containing ion exchange resin particles. This invention addresses the quality control of liquid drug suspensions and includes methods for confirming the acceptability of drug-containing resin particles.
Career Highlights
Lockhart is currently associated with Neos Therapeutics, LP, where he continues to push the boundaries of pharmaceutical innovation. His work has been instrumental in developing formulations that enhance the efficacy and safety of drug delivery systems.
Collaborations
Some of his notable coworkers include Mark Tengler and Russell McMahen, who contribute to the collaborative environment that fosters innovation at Neos Therapeutics.
Conclusion
Daniel Lockhart's contributions to pharmaceutical formulations exemplify the importance of innovation in the healthcare sector. His patents reflect a commitment to improving drug delivery systems, ultimately benefiting patients and healthcare providers alike.